An in-depth look to SIPAI HEALTH TECHNOLOGY COMPANY., LIMITED. operating, investing, and financing activities

AX1 free cash flow for H2 24 is -13.15 M EUR. For 2024, AX1 free cash flow was -13.38 M EUR and operating cash flow was -12.24 M EUR.